← Back to patent-cliff list
Glucosamine Hydrochloride
Tier C — Watch / tradeGlucosamine Hydrochloride
-
Originator
2004
First approval
-
Expiry (public)
No sales data
Peak sales
Small molecule
Type
Targets：NF-κB
Brand：Dolenio, Viartril-S, Dona 200-S, Xicil, Dona
Indications (approved)：Osteoarthritis
Regional status
US
No progress
2000-04-01
EU
-
China
Approved
2004-03-17
Japan
-
Synthetic routes & intermediates
Routes not yet onboarded — the daily pipeline enriches by priority (approved small molecules first); this page updates automatically.
Frequently asked questions
What are the approved indications of Glucosamine Hydrochloride?
Approved indications include: Osteoarthritis.
When does the Glucosamine Hydrochloride patent expire?
No public expiry year is available for Glucosamine Hydrochloride yet; this page updates once verified.
How do I get a quote for Glucosamine Hydrochloride intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-09-27